Saud Al Babtain Cardiac Center Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2018
NCT04303390
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Saud Al Babtain Cardiac Center | Saud AlBabtain Cardiac Center

Active Ingredients

Drugs in Phase 4 Trials (2)

cefazolin (ancef) (1 trial)

cefuroxime (zinacef) (1 trial)

Drugs in Phase 3 Trials (2)

apixaban (eliquis) (1 trial)

warfarin (coumadin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 4)

Infections (Phase 4)

Surgical Wound Infection (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 4